<DOC>
	<DOCNO>NCT00288249</DOCNO>
	<brief_summary>The purpose study determine whether study drug effective safe treatment patient metastatic breast cancer</brief_summary>
	<brief_title>Safety Efficacy Study New Chemotherapy Agent Treat Metastatic Breast Cancer</brief_title>
	<detailed_description>The study previously post Schering AG , Germany . Schering AG , Germany rename Bayer Schering Pharma AG , Germany.Bayer Schering Pharma AG , Germany sponsor trial .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Epothilones</mesh_term>
	<criteria>Metastatic breast cancer No previous treatment taxanes , vinca alkaloid Use highly effective birth control method female childbearing potential More 2 previous chemotherapy Previous participation another trial within last 4 week Breast feed Active infection</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Breast Neoplasms</keyword>
</DOC>